IP Library › Granted Patent US 7,951,377
Granted Patent B2
US 7,951,377 · App. 12/192,015 · Granted May 31, 2011

Mosaic clade M human immunodeficiency virus type 1 (HIV-1) envelope immunogens

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,951,377
App. No.
12/192,015
Granted
May 31, 2011
Kind
B2
Abstract

The present invention relates to mosaic clade M HIV-1 Env polypeptides and to compositions comprising same. The polypeptides of the invention are suitable for use in inducing an immune response to HIV-1 in a human.

Claims (6)

1. An isolated and purified mosaic clade M human immunodeficiency virus type 1 (HIV-1) Env polypeptide comprising an amino acid sequence selected from the group consisting of M_mos_Env — 3 — 1 (SEQ ID NO:177), M_mos_Env — 3 — 2 (SEQ ID NO:178) and M_mos_Env — 3 — 3 (SEQ ID NO:179).

2. The polypeptide according to claim 1 wherein said polypeptide comprises the amino acid of SEQ ID NO:177.

3. The polypeptide according to claim 1 wherein said polypeptide comprises the amino acid of SEQ ID NO:178.

4. The polypeptide according to claim 1 wherein said polypeptide comprises the amino acid of SEQ ID NO:179.

5. A composition comprising the polypeptide according to claim 1 and a carrier.

6. A method of inducing an immune response against HIV-1 in a host comprising administering to said host an amount of the polypeptide according to claim 1 sufficient to induce said response.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2018
From: LOS ALAMOS NATIONAL SECURITY, LLC
To: TRIAD NATIONAL SECURITY, LLC
Reel/Frame 047485/0173 →